Bob is a senior executive with over 30 years of leadership experience in healthcare services, healthcare IT, and surgical devices with major international companies, as well as entrepreneurial startups and venture capital. He is well-recognized for creating value, with experience in mergers and acquisitions, public corporations, venture capital firms, and startups.
Today, Bob is leveraging his healthcare industry and venture capital experience as the Managing Director of Hotspot Ventures, LLC. Hotspot Ventures only works with private capital backed healthcare companies as a strategic advisor, independent board member or executive chairman. He is a member of the board of directors for Synaptrix, a medical device company focused on post-surgical pain management using neuromodulation to allow hip and shoulder surgery patients to be pain free for 17 to 21 days post-op, for OrbitalRx, a pharmacy shortage supply chain software company in Winston-Salem, N.C., and for Pictor Labs, a digital pathology staining company in Los Angeles, Calif. He is an independent member of the board of directors for AllerVie, an asthma and allergy practice rollup company in Dallas, Tex., for Venostent, a medical device company focused on improving the quality and length of life for dialysis patients in Houston, TX, and Plueral Dynamics, a medical device company helping clinicians treat and manage chronic, recurrent fluid collections within the body in Wayzata, Minn. He is also a strategic advisor for Bronze Valley, a not-for-profit CDFI focused on investing in companies founded and/or led by under-resourced entrepreneurs in Birmingham, Ala, as well as Good Growth Capital, an early-stage venture capital investment firm in Charleston, S.C.
Prior to this work, he served as the founding managing director for the American Cancer Society’s BrightEdge Fund, where he built the back office, hired the initial team, led the first five investments, and realized an early exit in Castle Biosciences.
Before BrightEdge, he was a partner at Harbert Growth Partners in Birmingham, Ala. He led investments in WellCentive, IngagePatient, Caresync and Shipt. He also served as the board observer for nContact, MaxCyte, OpenQ and WiserTogether, among others.
Bob also served as the senior vice president/general manager of the Pharmaceutical Services Division at US Oncology, a privately held, vertically integrated cancer care provider network with cancer clinics in more than 440 sites of service and a physician network consisting of over 1200 medical oncologists and radiation oncologists that was acquired by McKesson. Prior to US Oncology, he was a senior executive at CardinalHealth where he served as vice president/general manager of New Ventures. Prior to Cardinal he was the founder and CEO of Surgical Innovations & Services, Inc. (SIS). Under his leadership, SIS became a leader in the emerging outsource management sector, with over 300 hospitals and surgery centers under contract before being acquired by PhotoMedex.
Bob serves on the boards of Health Connect South and SC Launch. He is a graduate of the University of Georgia and holds Bachelor of Science degrees in Political Science and Chemistry. He resides in Charleston, S.C.
